Otolaryngology · Birmingham, AL
NPI
1912341892
Since 2013
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
48 Medical Park Dr E Ste 153
Birmingham, AL, 35235
Phone (205) 402-8133
Groups this clinician bills Medicare through
Medicare paid, 2024
$263K
2,865 services
Medicare patients, 2024
472
Average age 74
Drug cost, 2024
$180K
5,161 prescriptions
Company payments, 2025
$1,345
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher M Clark was code 99214 (office e&m - established), 312 times for 221 patients. In total Christopher M Clark billed 2,865 services in 94 codes, and Medicare paid $263K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 312 | 221 | $87.69 | $27K |
| 99213 Office E&M - Established | Office | 241 | 166 | $62.48 | $15K |
| 31231 Nasal/Sinus Endoscopy | Office | 206 | 141 | $131.85 | $27K |
| 99204 Office E&M - New | Office | 145 | 145 | $114.22 | $17K |
| 69210 Other Organ Systems | Office | 135 | 108 | $30.71 | $4,146 |
| 76377 Standard X-ray | Office | 126 | 114 | $58.10 | $7,320 |
| 70486 CT/CTA - Head and Neck | Office | 126 | 114 | $96.18 | $12K |
| 92504 E&M - Miscellaneous | Office | 119 | 99 | $20.15 | $2,398 |
| 31237 Nasal/Sinus Endoscopy | Office | 105 | 52 | $277.50 | $29K |
| 31575 Other Organ Systems | Office | 87 | 71 | $91.48 | $7,959 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 68 | 16 | $0.34 | $23.23 |
| 99203 Office E&M - New | Office | 61 | 61 | $70.72 | $4,314 |
| 95027 Test - Miscellaneous | Office | 49 | 12 | $3.48 | $171 |
| 96372 Injection Administration | Office | 40 | 22 | $10.49 | $420 |
| 30140 Other Organ Systems | Facility | 30 | 30 | $103.26 | $3,098 |
By year: 2022 $137K for 1,823 services; 2023 $218K for 2,817 services; 2024 $263K for 2,865 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher M Clark prescribed most often to Medicare patients was Fluticasone Propionate, with 910 prescriptions and refills. In total Christopher M Clark wrote 5,161 Medicare prescriptions that cost $180K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 910 | 1,279 | 432 | $14K |
| Azelastine Hcl Generic | 615 | 761 | 275 | $18K |
| Prednisone Generic | 394 | 394 | 333 | $2,027 |
| Famotidine Generic | 351 | 475 | 144 | $3,635 |
| Pantoprazole Sodium Generic | 329 | 501 | 151 | $1,946 |
| Ipratropium Bromide Generic | 325 | 468 | 134 | $11K |
| Levocetirizine Dihydrochloride Generic | 302 | 481 | 115 | $2,582 |
| Montelukast Sodium Generic | 269 | 465 | 111 | $2,573 |
| Mupirocin Generic | 199 | 199 | 136 | $1,555 |
| Nortriptyline Hcl Generic | 195 | 257 | 88 | $1,226 |
| Doxycycline Monohydrate Generic | 188 | 188 | 159 | $3,781 |
| Mometasone Furoate Generic | 141 | 144 | 105 | $2,570 |
| Methylprednisolone Generic | 124 | 124 | 115 | $1,032 |
| Neomycin-Polymyxin-Hc Neomycin/Polymyxin B/Hydrocort | 124 | 124 | 91 | $6,581 |
| Doxycycline Hyclate Generic | 112 | 112 | 109 | $834 |
Brand drugs: - claims; generic drugs: 5,074 claims; opioid claims: 121.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher M Clark $1,345 ($1,345 in general payments such as food, travel and fees) from 17 companies. The largest payer was GlaxoSmithKline, LLC. with $311.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 13 | $311 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $262 |
| Genzyme Corporation SNY | 6 | $206 |
| Abbvie Inc. ABBV | 5 | $89.31 |
| Amgen Inc. AMGN | 3 | $58.86 |
| Optinose US, Inc. | 2 | $56.62 |
| Pfizer Inc. PFE | 3 | $50.75 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $46.9 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $46.08 |
| Inspire Medical Systems, Inc. INSP | 1 | $36.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.